Enhanced Prosthetic Heart Valve with Advanced Features

Publication ID: 24-11857411_0001_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Prosthetic Heart Valve with Advanced Features,” Published Technical Disclosure No. 24-11857411_0001_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857411_0001_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,411.

Summary of the Inventive Concept

An improved prosthetic heart valve with novel features that enhance its performance, durability, and implantation procedure, addressing the limitations of existing prosthetic heart valves.

Background and Problem Solved

The original patent disclosed a prosthetic heart valve with an annular frame and a leaflet structure. However, the existing design has limitations, such as the need for precise suture placement, risk of calcification, and potential for turbulence. The new inventive concept addresses these limitations by introducing an adjustable suture system, anti-calcification coating, and novel leaflet geometry.

Detailed Description of the Inventive Concept

The enhanced prosthetic heart valve comprises an annular frame with an inflow end and an outflow end, radially collapsible and expandable between a radially collapsed configuration and a radially expanded configuration. The leaflet structure is positioned within the frame and secured thereto with a novel, adjustable suture system, allowing for post-implantation adjustments to optimize valve performance. Additionally, the leaflet structure may be treated with an anti-calcification coating to reduce calcification and improve durability. Alternatively, the leaflet structure may be designed with a novel, asymmetrical leaflet geometry that improves blood flow and reduces turbulence. The valve may be delivered using a novel, expandable sheath that facilitates smooth, low-friction delivery to a target site within a patient's heart.

Novelty and Inventive Step

The new claims introduce novel features that are not obvious from the original patent, including the adjustable suture system, anti-calcification coating, and novel leaflet geometry. These features provide significant improvements over the existing design, enhancing the valve's performance, durability, and implantation procedure.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include different materials for the leaflet structure, varying thicknesses for the anti-calcification coating, or modified geometries for the leaflet structure. Additionally, the valve may be designed for use in different anatomical locations or for pediatric applications.

Potential Commercial Applications and Market

The enhanced prosthetic heart valve has significant commercial potential in the cardiovascular medical device industry, offering improved performance, durability, and implantation procedure. The target market includes cardiologists, cardiothoracic surgeons, and medical device companies focused on heart valve replacement and repair.

CPC Classifications

SectionClassGroup
A A61 A61F2/2409
A A61 A61F2/2415
A A61 A61F2/2418
A A61 A61L27/3625
A A61 A61L27/50
A A61 A61L27/56
A A61 A61F2/2427
A A61 A61F2230/0054
A A61 A61F2240/001
A A61 A61F2250/0063
A A61 A61F2250/0069
A A61 A61L2430/20

Field of Art

Cardiovascular medical devices, specifically implantable prosthetic heart valves, requiring advanced knowledge of biomechanical engineering, surgical techniques, and materials science with expertise in medical device design and cardiovascular interventional procedures

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or cardiovascular medical device designer with advanced degree, 5-10 years experience, familiar with prosthetic valve technologies, surgical implantation techniques, and materials engineering for biological interfaces

Obviousness Rationale

A skilled practitioner would recognize that the PTD's variations represent predictable engineering improvements to the source patent's fundamental prosthetic valve design. The disclosed modifications such as adjustable suture systems, anti-calcification treatments, and asymmetrical leaflet geometries are logical extensions of existing cardiovascular device optimization strategies. These variations demonstrate incremental technical advancements that would be apparent to a person skilled in prosthetic heart valve development.

Obvious Combinations & Variations

Source Patent Element
Radially collapsible annular frame with leaflet structure
PTD Variation
Adjustable suture system for post-implantation leaflet configuration
Obviousness Reasoning
Known surgical technique of intraoperative device adjustment, representing a predictable design optimization for improved valve performance
Source Patent Element
Pericardial tissue outer skirt
PTD Variation
Anti-calcification coating applied to leaflet structure
Obviousness Reasoning
Standard materials engineering approach to extending implant durability, using well-established surface modification techniques
Source Patent Element
Expandable prosthetic valve design
PTD Variation
Novel asymmetrical leaflet geometry to improve blood flow
Obviousness Reasoning
Finite design solution for reducing hemodynamic turbulence, representing a straightforward geometric optimization known in cardiovascular device engineering
Source Patent Element
Implantable prosthetic valve with collapsible frame
PTD Variation
Expandable low-friction delivery sheath
Obviousness Reasoning
Predictable technological improvement in minimally invasive surgical device deployment, addressing known challenges in valve implantation
Source Patent Element
Basic prosthetic valve structural configuration
PTD Variation
Alternative material compositions and coating variations
Obviousness Reasoning
Routine materials selection and surface modification representing standard design iteration in medical device development
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this Published Technical Disclosure would have been obvious to a Person Having Ordinary Skill In The Art at the time of invention, when considering the teachings of US Patent 11857411. The incremental technical modifications represent predictable engineering solutions within the established technological framework of prosthetic heart valve design, thereby rendering potential patent claims obvious and anticipatable by the prior art.

Original Patent Information

Patent NumberUS 11,857,411
TitlePericardial sealing member for prosthetic heart valve
Assignee(s)EDWARDS LIFESCIENCES CORPORATION